{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:05:47Z","timestamp":1790744747415,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,10,20]],"date-time":"2017-10-20T00:00:00Z","timestamp":1508457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    De novo mutations in specific mTOR pathway genes cause brain overgrowth in the context of intellectual disability (ID). By analyzing 101 mMTOR-related genes in a large ID patient cohort and two independent population cohorts, we show that these genes modulate brain growth in health and disease. We report the mTOR activator gene\n                    <jats:italic>RHEB<\/jats:italic>\n                    as an ID gene that is associated with megalencephaly when mutated. Functional testing of mutant\n                    <jats:italic>RHEB<\/jats:italic>\n                    in vertebrate animal models indicates pathway hyperactivation with a concomitant increase in cell and head size, aberrant neuronal migration, and induction of seizures, concordant with the human phenotype. This study reveals that tight control of brain volume is exerted through a large community of mTOR-related genes. Human brain volume can be altered, by either rare disruptive events causing hyperactivation of the pathway, or through the collective effects of common alleles.\n                  <\/jats:p>","DOI":"10.1038\/s41467-017-00933-6","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T05:03:21Z","timestamp":1508130201000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Variation in a range of mTOR-related genes associates with intracranial volume and intellectual disability"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6379-7147","authenticated-orcid":false,"given":"M. R. F.","family":"Reijnders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M.","family":"van Woerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8784-5679","authenticated-orcid":false,"given":"M.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bralten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. M. S.","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"van Essen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Proietti-Onori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. E. J.","family":"Smeets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van Gastel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P. A.","family":"Stegmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. J. C.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.","family":"Lelieveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1693-9699","authenticated-orcid":false,"given":"C.","family":"Gilissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pfundt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. L.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kleefstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4375-6572","authenticated-orcid":false,"given":"B.","family":"Franke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Elgersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Katsanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. G.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,20]]},"reference":[{"key":"933_CR1","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1002\/hbm.20398","volume":"28","author":"JS Peper","year":"2007","unstructured":"Peper, J. S., Brouwer, R. M., Boomsma, D. I., Kahn, R. S. & Hulshoff Pol, H. E. Genetic influences on human brain structure: a review of brain imaging studies in twins. Hum. Brain Mapp. \n                           28, 464\u2013473 (2007).","journal-title":"Hum. Brain Mapp."},{"key":"933_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/nature14101","volume":"520","author":"DP Hibar","year":"2015","unstructured":"Hibar, D. P. et al. Common genetic variants influence human subcortical brain structures. Nature \n                           520, 224\u2013229 (2015).","journal-title":"Nature"},{"key":"933_CR3","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1056\/NEJMoa1206524","volume":"367","author":"J de Ligt","year":"2012","unstructured":"de Ligt, J. et al. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. \n                           367, 1921\u20131929 (2012).","journal-title":"N. Engl. J. Med."},{"key":"933_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.035","volume":"169","author":"RA Saxton","year":"2017","unstructured":"Saxton, R. A. & Sabatini, D. M. mTOR signaling in growth, metabolism, and disease. Cell \n                           169, 361\u2013371 (2017).","journal-title":"Cell"},{"key":"933_CR5","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/S0960-9822(03)00506-2","volume":"13","author":"AR Tee","year":"2003","unstructured":"Tee, A. R., Manning, B. D., Roux, P. P., Cantley, L. C. & Blenis, J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. \n                           13, 1259\u20131268 (2003).","journal-title":"Curr. Biol."},{"key":"933_CR6","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.neuron.2006.03.023","volume":"50","author":"CH Kwon","year":"2006","unstructured":"Kwon, C. H. et al. Pten regulates neuronal arborization and social interaction in mice. Neuron \n                           50, 377\u2013388 (2006).","journal-title":"Neuron"},{"key":"933_CR7","doi-asserted-by":"publisher","first-page":"33784","DOI":"10.1074\/jbc.M802431200","volume":"283","author":"YH Li","year":"2008","unstructured":"Li, Y. H., Werner, H. & Puschel, A. W. Rheb and mTOR regulate neuronal polarity through Rap1B. J. Biol. Chem. \n                           283, 33784\u201333792 (2008).","journal-title":"J. Biol. Chem."},{"key":"933_CR8","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nn.2477","volume":"13","author":"D Nie","year":"2010","unstructured":"Nie, D. et al. Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nat. Neurosci. \n                           13, 163\u2013172 (2010).","journal-title":"Nat. Neurosci."},{"key":"933_CR9","doi-asserted-by":"publisher","first-page":"30240","DOI":"10.1074\/jbc.M112.374405","volume":"287","author":"M Urbanska","year":"2012","unstructured":"Urbanska, M., Gozdz, A., Swiech, L. J. & Jaworski, J. Mammalian target of rapamycin complex 1 (mTORC1) and 2 (mTORC2) control the dendritic arbor morphology of hippocampal neurons. J. Biol. Chem. \n                           287, 30240\u201330256 (2012).","journal-title":"J. Biol. Chem."},{"key":"933_CR10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.celrep.2013.09.017","volume":"5","author":"NW Hartman","year":"2013","unstructured":"Hartman, N. W. et al. mTORC1 targets the translational repressor 4E-BP2, but not S6 kinase 1\/2, to regulate neural stem cell self-renewal in vivo. Cell Rep. \n                           5, 433\u2013444 (2013).","journal-title":"Cell Rep."},{"key":"933_CR11","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1038\/nn1566","volume":"8","author":"SF Tavazoie","year":"2005","unstructured":"Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J. & Sabatini, B. L. Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2. Nat. Neurosci. \n                           8, 1727\u20131734 (2005).","journal-title":"Nat. Neurosci."},{"key":"933_CR12","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1172\/JCI44909","volume":"121","author":"DM Feliciano","year":"2011","unstructured":"Feliciano, D. M., Su, T., Lopez, J., Platel, J. C. & Bordey, A. Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J. Clin. Invest. \n                           121, 1596\u20131607 (2011).","journal-title":"J. Clin. Invest."},{"key":"933_CR13","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1101\/gad.16750211","volume":"25","author":"J Zhou","year":"2011","unstructured":"Zhou, J. et al. Tsc1 mutant neural stem\/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle. Genes Dev. \n                           25, 1595\u20131600 (2011).","journal-title":"Genes Dev."},{"key":"933_CR14","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/nm.3982","volume":"21","author":"ST Baek","year":"2015","unstructured":"Baek, S. T. et al. An AKT3-FOXG1-reelin network underlies defective migration in human focal malformations of cortical development. Nat. Med. \n                           21, 1445\u20131454 (2015).","journal-title":"Nat. Med."},{"key":"933_CR15","doi-asserted-by":"publisher","first-page":"11330","DOI":"10.1073\/pnas.1605740113","volume":"113","author":"TV Lin","year":"2016","unstructured":"Lin, T. V., Hsieh, L., Kimura, T., Malone, T. J. & Bordey, A. Normalizing translation through 4E-BP prevents mTOR-driven cortical mislamination and ameliorates aberrant neuron integration. Proc. Natl Acad. Sci. USA \n                           113, 11330\u201311335 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"933_CR16","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.celrep.2015.07.013","volume":"12","author":"UY Moon","year":"2015","unstructured":"Moon, U. Y. et al. Impaired reelin-dab1 signaling contributes to neuronal migration deficits of tuberous sclerosis complex. Cell Rep. \n                           12, 965\u2013978 (2015).","journal-title":"Cell Rep."},{"key":"933_CR17","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1523\/JNEUROSCI.1840-12.2013","volume":"33","author":"CA Lafourcade","year":"2013","unstructured":"Lafourcade, C. A. et al. Rheb activation in subventricular zone progenitors leads to heterotopia, ectopic neuronal differentiation, and rapamycin-sensitive olfactory micronodules and dendrite hypertrophy of newborn neurons. J. Neurosci. \n                           33, 2419\u20132431 (2013).","journal-title":"J. Neurosci."},{"key":"933_CR18","doi-asserted-by":"publisher","first-page":"8862","DOI":"10.1523\/JNEUROSCI.1617-11.2011","volume":"31","author":"HS Bateup","year":"2011","unstructured":"Bateup, H. S., Takasaki, K. T., Saulnier, J. L., Denefrio, C. L. & Sabatini, B. L. Loss of Tsc1 in vivo impairs hippocampal mGluR-LTD and increases excitatory synaptic function. J. Neurosci. \n                           31, 8862\u20138869 (2011).","journal-title":"J. Neurosci."},{"key":"933_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7842","volume":"6","author":"H Sugiura","year":"2015","unstructured":"Sugiura, H. et al. Rheb activation disrupts spine synapse formation through accumulation of syntenin in tuberous sclerosis complex. Nat. Commun. \n                           6, 6842 (2015).","journal-title":"Nat. Commun."},{"key":"933_CR20","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.neuron.2014.07.040","volume":"83","author":"G Tang","year":"2014","unstructured":"Tang, G. et al. Loss of mTOR-dependent macroautophagy causes autistic-like synaptic pruning deficits. Neuron \n                           83, 1131\u20131143 (2014).","journal-title":"Neuron"},{"key":"933_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5563","volume":"5","author":"N Lozovaya","year":"2014","unstructured":"Lozovaya, N. et al. Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model. Nat. Commun. \n                           5, 4563 (2014).","journal-title":"Nat. Commun."},{"key":"933_CR22","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1152\/jn.00342.2012","volume":"109","author":"CA Hoeffer","year":"2013","unstructured":"Hoeffer, C. A. et al. Multiple components of eIF4F are required for protein synthesis-dependent hippocampal long-term potentiation. J. Neurophysiol. \n                           109, 68\u201376 (2013).","journal-title":"J. Neurophysiol."},{"key":"933_CR23","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nature11782","volume":"493","author":"E Santini","year":"2013","unstructured":"Santini, E. et al. Exaggerated translation causes synaptic and behavioural aberrations associated with autism. Nature \n                           493, 411\u2013415 (2013).","journal-title":"Nature"},{"key":"933_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nature11083","volume":"485","author":"CC Thoreen","year":"2012","unstructured":"Thoreen, C. C. et al. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature \n                           485, 109\u2013113 (2012).","journal-title":"Nature"},{"key":"933_CR25","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1126\/science.1131693","volume":"314","author":"KF Raab-Graham","year":"2006","unstructured":"Raab-Graham, K. F., Haddick, P. C., Jan, Y. N. & Jan, L. Y. Activity- and mTOR-dependent suppression of Kv1.1 channel mRNA translation in dendrites. Science \n                           314, 144\u2013148 (2006).","journal-title":"Science"},{"key":"933_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13421","volume":"7","author":"WC Huang","year":"2016","unstructured":"Huang, W. C., Chen, Y. & Page, D. T. Hyperconnectivity of prefrontal cortex to amygdala projections in a mouse model of macrocephaly\/autism syndrome. Nat. Commun. \n                           7, 13421 (2016).","journal-title":"Nat. Commun."},{"key":"933_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1093\/hmg\/ddq491","volume":"20","author":"LH Zeng","year":"2011","unstructured":"Zeng, L. H. et al. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum. Mol. Genet. \n                           20, 445\u2013454 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"933_CR28","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/ana.23943","volume":"74","author":"E Abs","year":"2013","unstructured":"Abs, E. et al. TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice. Ann. Neurol. \n                           74, 569\u2013579 (2013).","journal-title":"Ann. Neurol."},{"key":"933_CR29","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.neuron.2012.08.002","volume":"75","author":"RY Pun","year":"2012","unstructured":"Pun, R. Y. et al. Excessive activation of mTOR in postnatally generated granule cells is sufficient to cause epilepsy. Neuron. \n                           75, 1022\u20131034 (2012).","journal-title":"Neuron."},{"key":"933_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11753","volume":"7","author":"LS Hsieh","year":"2016","unstructured":"Hsieh, L. S. et al. Convulsive seizures from experimental focal cortical dysplasia occur independently of cell misplacement. Nat. Commun. \n                           7, 11753 (2016).","journal-title":"Nat. Commun."},{"key":"933_CR31","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/ana.21317","volume":"62","author":"SM Goorden","year":"2007","unstructured":"Goorden, S. M., van Woerden, G. M., van der Weerd, L., Cheadle, J. P. & Elgersma, Y. Cognitive deficits in Tsc1+\/\u2212 mice in the absence of cerebral lesions and seizures. Ann. Neurol. \n                           62, 648\u2013655 (2007).","journal-title":"Ann. Neurol."},{"key":"933_CR32","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1093\/hmg\/ddv087","volume":"24","author":"SM Goorden","year":"2015","unstructured":"Goorden, S. M. et al. Intact neuronal function in Rheb1 mutant mice: implications for TORC1-based treatments. Hum. Mol. Genet. \n                           24, 3390\u20133398 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"933_CR33","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","volume":"381","author":"DN Franz","year":"2013","unstructured":"Franz, D. N. et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet \n                           381, 125\u2013132 (2013).","journal-title":"Lancet"},{"key":"933_CR34","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1212\/WNL.0000000000003077","volume":"87","author":"IE Overwater","year":"2016","unstructured":"Overwater, I. E. et al. Sirolimus for epilepsy in children with tuberous sclerosis complex: a randomized controlled trial. Neurology \n                           87, 1011\u20131018 (2016).","journal-title":"Neurology"},{"key":"933_CR35","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","volume":"388","author":"JA French","year":"2016","unstructured":"French, J. A. et al. Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): a phase 3, randomised, double-blind, placebo-controlled study. Lancet \n                           388, 2153\u20132163 (2016).","journal-title":"Lancet"},{"key":"933_CR36","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ebcr.2015.06.008","volume":"4","author":"JW Wheless","year":"2015","unstructured":"Wheless, J. W. Use of the mTOR inhibitor everolimus in a patient with multiple manifestations of tuberous sclerosis complex including epilepsy. Epilepsy Behav. Case Rep. \n                           4, 63\u201366 (2015).","journal-title":"Epilepsy Behav. Case Rep."},{"key":"933_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035885","volume":"7","author":"DM Talos","year":"2012","unstructured":"Talos, D. M. et al. The interaction between early life epilepsy and autistic-like behavioral consequences: a role for the mammalian target of rapamycin (mTOR) pathway. PLoS ONE \n                           7, e35885 (2012).","journal-title":"PLoS ONE"},{"key":"933_CR38","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/ng.2331","volume":"44","author":"JB Riviere","year":"2012","unstructured":"Riviere, J. B. et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat. Genet. \n                           44, 934\u2013940 (2012).","journal-title":"Nat. Genet."},{"key":"933_CR39","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/ng.2329","volume":"44","author":"JH Lee","year":"2012","unstructured":"Lee, J. H. et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat. Genet. \n                           44, 941\u2013945 (2012).","journal-title":"Nat. Genet."},{"key":"933_CR40","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/jamaneurol.2016.0363","volume":"73","author":"GM Mirzaa","year":"2016","unstructured":"Mirzaa, G. M. et al. Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism. JAMA Neurol. \n                           73, 836\u2013845 (2016).","journal-title":"JAMA Neurol."},{"key":"933_CR41","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nm.3824","volume":"21","author":"JS Lim","year":"2015","unstructured":"Lim, J. S. et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat. Med. \n                           21, 395\u2013400 (2015).","journal-title":"Nat. Med."},{"key":"933_CR42","volume":"8","author":"HH Adams","year":"2016","unstructured":"Adams, H. H. et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat Neurosci \n                           8, 13624 (2016).","journal-title":"Nat Neurosci."},{"key":"933_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2014.00028","volume":"7","author":"N Takei","year":"2014","unstructured":"Takei, N. & Nawa, H. mTOR signaling and its roles in normal and abnormal brain development. Front. Mol. Neurosci. \n                           7, 28 (2014).","journal-title":"Front. Mol. Neurosci."},{"key":"933_CR44","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.celrep.2014.04.048","volume":"7","author":"H Kassai","year":"2014","unstructured":"Kassai, H. et al. Selective activation of mTORC1 signaling recapitulates microcephaly, tuberous sclerosis, and neurodegenerative diseases. Cell Rep. \n                           7, 1626\u20131639 (2014).","journal-title":"Cell Rep."},{"key":"933_CR45","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1038\/nrn2097","volume":"8","author":"C Dehay","year":"2007","unstructured":"Dehay, C. & Kennedy, H. Cell-cycle control and cortical development. Nat. Rev. Neurosci. \n                           8, 438\u2013450 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"933_CR46","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nrn2151","volume":"8","author":"BJ Molyneaux","year":"2007","unstructured":"Molyneaux, B. J., Arlotta, P., Menezes, J. R. & Macklis, J. D. Neuronal subtype specification in the cerebral cortex. Nat. Rev. Neurosci. \n                           8, 427\u2013437 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"933_CR47","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nbd.2009.02.008","volume":"38","author":"R Guerrini","year":"2010","unstructured":"Guerrini, R. & Parrini, E. Neuronal migration disorders. Neurobiol. Dis. \n                           38, 154\u2013166 (2010).","journal-title":"Neurobiol. Dis."},{"key":"933_CR48","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3858\/emm.2011.43.5.032","volume":"43","author":"CH Cho","year":"2011","unstructured":"Cho, C. H. Frontier of epilepsy research - mTOR signaling pathway. Exp. Mol. Med. \n                           43, 231\u2013274 (2011).","journal-title":"Exp. Mol. Med."},{"key":"933_CR49","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1172\/JCI79860","volume":"125","author":"G Houge","year":"2015","unstructured":"Houge, G. et al. B56delta-related protein phosphatase 2A dysfunction identified in patients with intellectual disability. J. Clin. Invest. \n                           125, 3051\u20133062 (2015).","journal-title":"J. Clin. Invest."},{"key":"933_CR50","doi-asserted-by":"publisher","first-page":"R133","DOI":"10.1093\/hmg\/ddw249","volume":"25","author":"TH Pers","year":"2016","unstructured":"Pers, T. H. Gene set analysis for interpreting genetic studies. Hum. Mol. Genet. \n                           25, R133\u2013R140 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"933_CR51","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrn3707","volume":"15","author":"T Sun","year":"2014","unstructured":"Sun, T. & Hevner, R. F. Growth and folding of the mammalian cerebral cortex: from molecules to malformations. Nat. Rev. Neurosci. \n                           15, 217\u2013232 (2014).","journal-title":"Nat. Rev. Neurosci."},{"key":"933_CR52","doi-asserted-by":"publisher","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","volume":"28","author":"L Meikle","year":"2008","unstructured":"Meikle, L. et al. Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J. Neurosci. \n                           28, 5422\u20135432 (2008).","journal-title":"J. Neurosci."},{"key":"933_CR53","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/j.ajpath.2017.01.015","volume":"187","author":"S Hanai","year":"2017","unstructured":"Hanai, S. et al. Pathologic active mTOR mutation in brain malformation with intractable epilepsy leads to cell-autonomous migration delay. Am. J. Pathol. \n                           187, 1177\u20131185 (2017).","journal-title":"Am. J. Pathol."},{"key":"933_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123092","volume":"10","author":"DC Loconte","year":"2015","unstructured":"Loconte, D. C. et al. Molecular and functional characterization of three different postzygotic mutations in PIK3CA-related overgrowth spectrum (PROS) patients: effects on PI3K\/AKT\/mTOR signaling and sensitivity to PIK3 inhibitors. PLoS ONE \n                           10, e0123092 (2015).","journal-title":"PLoS ONE"},{"key":"933_CR55","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.cmet.2013.02.008","volume":"17","author":"Y Fang","year":"2013","unstructured":"Fang, Y. et al. Duration of rapamycin treatment has differential effects on metabolism in mice. Cell Metab. \n                           17, 456\u2013462 (2013).","journal-title":"Cell Metab."},{"key":"933_CR56","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/nn.4352","volume":"19","author":"SH Lelieveld","year":"2016","unstructured":"Lelieveld, S. H. et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat. Neurosci. \n                           19, 1194\u20131196 (2016).","journal-title":"Nat. Neurosci."},{"key":"933_CR57","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell \n                           149, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"933_CR58","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm3757","volume":"15","author":"M Shimobayashi","year":"2014","unstructured":"Shimobayashi, M. & Hall, M. N. Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat. Rev. Mol. Cell. Biol. \n                           15, 155\u2013162 (2014).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"933_CR59","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nrm1743","volume":"6","author":"W Kolch","year":"2005","unstructured":"Kolch, W. Coordinating ERK\/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell. Biol. \n                           6, 827\u2013837 (2005).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"933_CR60","doi-asserted-by":"publisher","first-page":"D804","DOI":"10.1093\/nar\/gkw865","volume":"45","author":"TN Turner","year":"2017","unstructured":"Turner, T. N. et al. denovo-db: a compendium of human de novo variants. Nucleic Acids Res. \n                           45, D804\u2013D811 (2017).","journal-title":"Nucleic Acids Res."},{"key":"933_CR61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11682-013-9269-5","volume":"8","author":"PM Thompson","year":"2014","unstructured":"Thompson, P. M. et al. The ENIGMA Consortium: large-scale collaborative analyses of neuroimaging and genetic data. Brain Imaging Behav. \n                           8, 153\u2013182 (2014).","journal-title":"Brain Imaging Behav."},{"key":"933_CR62","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/CIRCGENETICS.108.829747","volume":"2","author":"BM Psaty","year":"2009","unstructured":"Psaty, B. M. et al. Cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ. Cardiovasc. Genet. \n                           2, 73\u201380 (2009).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"933_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004219","volume":"11","author":"CA de Leeuw","year":"2015","unstructured":"de Leeuw, C. A., Mooij, J. M., Heskes, T. & Posthuma, D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput. Biol. \n                           11, e1004219 (2015).","journal-title":"PLoS Comput. Biol."},{"key":"933_CR64","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/nature09534","volume":"467","author":"C Genomes Project","year":"2010","unstructured":"Genomes Project, C. et al. A map of human genome variation from population-scale sequencing. Nature \n                           467, 1061\u20131073 (2010).","journal-title":"Nature"},{"key":"933_CR65","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nrg.2016.29","volume":"17","author":"CA de Leeuw","year":"2016","unstructured":"de Leeuw, C. A., Neale, B. M., Heskes, T. & Posthuma, D. The statistical properties of gene-set analysis. Nat. Rev. Genet. \n                           17, 353\u2013364 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"933_CR66","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jmedgenet-2015-103336","volume":"52","author":"Z Perles","year":"2015","unstructured":"Perles, Z. et al. A human laterality disorder caused by a homozygous deleterious mutation in MMP21. J. Med. Genet. \n                           52, 840\u2013847 (2015).","journal-title":"J. Med. Genet."},{"key":"933_CR67","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0888-7543(90)90199-5","volume":"7","author":"RM Cawthon","year":"1990","unstructured":"Cawthon, R. M. et al. Identification and characterization of transcripts from the neurofibromatosis 1 region: the sequence and genomic structure of EVI2 and mapping of other transcripts. Genomics \n                           7, 555\u2013565 (1990).","journal-title":"Genomics"},{"key":"933_CR68","unstructured":"Goslink, G., Banker, G. Culturing Nerve Cells, (MIT Press, 1991)."},{"key":"933_CR69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1006\/dbio.2001.0439","volume":"240","author":"T Saito","year":"2001","unstructured":"Saito, T. & Nakatsuji, N. Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. Dev. Biol. \n                           240, 237\u2013246 (2001).","journal-title":"Dev. Biol."},{"key":"933_CR70","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1177\/1073858411399925","volume":"18","author":"Y Taniguchi","year":"2012","unstructured":"Taniguchi, Y., Young-Pearse, T., Sawa, A. & Kamiya, A. In utero electroporation as a tool for genetic manipulation in vivo to study psychiatric disorders: from genes to circuits and behaviors. Neuroscientist \n                           18, 169\u2013179 (2012).","journal-title":"Neuroscientist"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00933-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00933-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00933-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T16:42:11Z","timestamp":1671727331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-017-00933-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,20]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["933"],"URL":"https:\/\/doi.org\/10.1038\/s41467-017-00933-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732015148.793556414","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,20]]},"assertion":[{"value":"31 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"B.F. received educational speaking fees from Merz and Shire. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1052"}}